# MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1)

> **NCT07379905** · NA · NOT_YET_RECRUITING · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 182 (estimated)

## Conditions studied

- Low-grade Cervical Intraepithelial Neoplasia
- Moducare

## Interventions

- **DIETARY_SUPPLEMENT:** MODUCARE

## Key facts

- **NCT ID:** NCT07379905
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 182 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379905, "MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07379905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*